Research Article
Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy
| | | KKT group () | KSS group () |
| | Age, mean | 45.9 | 44.2 |
| | BMI (kg/m2), mean | 22.0 | 21.9 |
| | Primary disease, n (%) (duplication) | | | | Ovarian cancer | 7 (38%) | 2 (13%) | | Uterine cancer | 5 (28%) | 7 (47%) | | Cervical cancer | 5 (28%) | 6 (40%) | | Ovarian borderline malignant tumor | 1 (6%) | | | Carcinoma in situ of uterine cervix | 1 (6%) | |
| | Initial treatment | | | | Surgery (BSO) | 15 (83%) | 12 (80%) | | Surgery without BSO | 1 (6%) | 2 (13%) | | CCRT | 2 (11%) | 1 (7%) |
| | Complications (duplication) | | | | Hypertension | 1 (6%) | 1 (7%) | | Diabetes | | 1 (7%) | | Depression | 1 (6%) | | | Renal cell carcinoma | 1 (6%) | | | Deep vein thrombosis | 1 (6%) | | | Crohn’s disease | 1 (6%) | | | Systemic lupus erythematosus | 1 (6%) | | | Pulmonary embolism | 1 (6%) | |
|
|
BSO: bilateral salpingo-oophorectomy; CCRT: concurrent chemoradiotherapy.
|
